ReviewFrontiers in oncology2022

Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?

Kotaro Miyao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.